Taha Can TUMAN, Uğur ÇAKIR, Osman YILDIRIM

Olanzapine induced urinary incontinence

ISSN: 1302-6631
Yayın Aralığı: Yılda 6 Sayı
Başlangıç: 2000
Yayıncı: -

___

Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 2005;353:1209-1223.

Albaugh VL, Singareddy R, Mauger D, Lynch CJ. A double blind, placebo-controlled, randomized crossover study of the acute metabolic effects of olanzapine in healthy volunteers. PLoS One 2011;6:e22662.

Karabulut S, Ergül C, Öztürk M, Üçok A. The role of metformin and topiramate in reducing the side effects due to antipsychotics in patients with schizophrenia. Anatolian Journal of Psychiatry 2014; 15:174-180.

Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts E, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30:239-245.

Sagar R, Varghese ST, Balhara YP. Olanzapine-induced double incontinence. Indian J Med Sci 2005; 59:163-164.

Vernon LT, Fuller MA, Hattab H, Varnes KM. Olanzapineinduced urinary incontinence: treatment with ephedrine. J Clin Psychiatry 2000; 61:601-602.

Dada MU, Oluwole LO, Adegun PT, Tareo PO. Olanzapine as a cause of urinary incontinence: a case report. Iranian Journal of Psychiatry 2012; 7:146.

Warner JP, Harvey CA, Barnes TR. Clozapine and urinary incontinence. Int Clin Psychopharmacol 1994; 9:207-209.

Vera PL, Miranda-Sousa A, Nadelhaft I. Effects of two atypical neuroleptics, olanzapine and risperidone, on the function of the urinary bladder and the external urethral sphincter in anesthetized rats. BMC Pharmacol 2001; 1:4.